Evidence of overestimating prostate cancer mortality in Estonia: a population-based study.
Autorzy:
InnosK; Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia. Paapsi K; Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia. Alas I; Urology Centre, West Tallinn Central Hospital, Tallinn, Estonia. Baum P; Surgery Clinic, North Estonia Medical Centre, Tallinn, Estonia. Kivi M; Centre of Urology, East Tallinn Central Hospital, Tallinn, Estonia. Kovtun M; Surgery Clinic, Tartu University Hospital, Tartu, Estonia. Okas R; Urology Centre, West Tallinn Central Hospital, Tallinn, Estonia. Pokker H; Haematology and Oncology Clinic, North Estonia Medical Centre, Tallinn, Estonia. Rajevskaja O; Centre of Urology, East Tallinn Central Hospital, Tallinn, Estonia. Rautio A; Centre of Urology, East Tallinn Central Hospital, Tallinn, Estonia. Saretok M; Haematology and Oncology Clinic, North Estonia Medical Centre, Tallinn, Estonia. Valk E; Surgery Clinic, North Estonia Medical Centre, Tallinn, Estonia. Žarkovski M; Surgery Clinic, Tartu University Hospital, Tartu, Estonia. Denissov G; Causes of Death Registry, National Institute for Health Development, Tallinn, Estonia. Lang K; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2022 Oct-Dec; Vol. 56 (5-6), pp. 359-364. Date of Electronic Publication: 2022 Sep 08.
Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations.
Autorzy:
Sant M; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. Magri MC; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. Maurichi A; Melanoma and Sarcoma Surgical Unit, Foundation IRCCS National Cancer Institute, 20133 Milan, Italy. Lillini R; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. Bento MJ; North Region Cancer Registry of Portugal (RORENO), Cancer Epidemiology Group, IPO Porto Research Center, 4200-072 Porto, Portugal.; Department of Population Studies, Institute of Biomedical Sciences Abel Salazar, University of Porto, 4200-465 Porto, Portugal. Ardanaz E; Navarre Public Health Institute, 31006 Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Navarre Institute for Health Research (IdiSNA), 31006 Pamplona, Spain. Guevara M; Navarre Public Health Institute, 31006 Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Navarre Institute for Health Research (IdiSNA), 31006 Pamplona, Spain. InnosK; Department of Epidemiology and Biostatistics, National Institute for Health Development, 11619 Tallinn, Estonia. Marcos-Gragera R; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IdiBGi), 08908 Girona, Spain. Rubio-Casadevall J; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IdiBGi), 08908 Girona, Spain. Sánchez Pérez MJ; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.; Andalusian School of Public Health (EASP), Granada Cancer Registry, 18011 Granada, Spain.; The Biomedical Research Institute (ibs.GRANADA), 18014 Granada, Spain.; Department of Preventive Medicine and Public Health, University of Granada, 18011 Granada, Spain. Tumino R; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), 97100 Ragusa, Italy. Rugge M; Department of Medicine-DIMED, Surgical Pathology and Cytopathology Unit, Università degli Studi di Padova, 35139 Padova, Italy. Minicozzi P; Analytical Epidemiology and Health Impact Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.; Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. The Melanoma Hr Study Working Group
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Sep 08; Vol. 14 (18). Date of Electronic Publication: 2022 Sep 08.
Stage-specific survival differences between colon cancer subsites: a population-based study.
Autorzy:
Reima H; Department of Surgical Oncology, Haematology and Oncology Clinic, Tartu University Hospital, Tartu, Estonia.; Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. Soplepmann J; Department of Surgical Oncology, Haematology and Oncology Clinic, Tartu University Hospital, Tartu, Estonia.; Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. InnosK; Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies